Evidence map›Paper›PMID 31216252›Full record

Observational studyThe Journal of urology2019

Interpretation of Domain Scores on the EPIC-How Does the Domain Score Translate into Functional Outcomes?

Aaron A Laviana, Agustin Hernandez, Li-Ching Huang, Zhiguo Zhao, Tatsuki Koyama, Ralph Conwill, Karen Hoffman, Irene D Feurer, Michael Goodman, Ann S Hamilton and 10 more

Erratum issued Registry-linked trialAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in The Journal of urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07460726 (A Single Arm Prospective Study to Investigate the Impact of Stereotactic Body Radiation Therapy), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07460726 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Single Arm Prospective Study to Investigate the Impact of Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) on Sexual Dysfunction in Unfavorable Intermediate Risk Prostate Cancer

Typeobservational_patient_registrySponsorCancerCare ManitobaRan2026 to 2029Enrolled130ConditionsProstate Cancer (Adenocarcinoma), Erectile Abnormalities, Sexual Dysfunction MaleArmsSBRT combined with ADT
3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Aaron A LavianaDepartment of Urology, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Agustin HernandezDepartment of Urology, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Li-Ching HuangDepartment of Biostatistics, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Zhiguo ZhaoDepartment of Biostatistics, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Tatsuki KoyamaDepartment of Biostatistics, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Ralph ConwillOffice of Patient and Community Education, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Karen HoffmanDepartment of Radiation Oncology, University of Texas MD Anderson Center, Houston, Texas.
Irene D FeurerDepartment of Biostatistics, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Michael GoodmanDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia.
Ann S HamiltonDepartment of Preventive Medicine, Keck School of Medicine at University of Southern California, Los Angeles, California.
Xiao-Cheng WuDepartment of Epidemiology, Louisiana State University New Orleans School of Public Health, New Orleans, Louisiana.
Lisa E PaddockDepartment of Epidemiology, Cancer Institute of New Jersey, Rutgers Health, New Brunswick, New Jersey.
Antoinette StroupDepartment of Epidemiology, Cancer Institute of New Jersey, Rutgers Health, New Brunswick, New Jersey.
Matthew R CooperbergDepartment of Urology, University of California-San Francisco, San Francisco, California.
Mia HashibeDepartment of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Brock B O'NeilDepartment of Urology, University of Utah Health, Salt Lake City, Utah.
Sherrie H KaplanDepartment of Medicine, University of California-Irvine, Irvine, California.
Sheldon GreenfieldDepartment of Medicine, University of California-Irvine, Irvine, California.
David F PensonDepartment of Urology, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Daniel A BarocasDepartment of Urology, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

Funding

Surgical Oncology Training GrantT32CA106183 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI James Richard Goldenring · 2004 to 2026
$6.0M
10-year Comparative Effectiveness and Harms of Treatments for Prostate CancerR01CA230352 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BAROCAS, DANIEL A · 2019 to 2023
$3.1M
AHRQ HHS K12 HS022990AHRQ HHS R01 HS019356AHRQ HHS R01 HS022640NCI NIH HHS R01 CA230352NCI NIH HHS T32 CA106183
6 · The paper itself

Abstract

purposeThe EPIC-26 (Expanded Prostate Cancer Index Composite-Short Form) is a validated questionnaire for measuring health related quality of life. However, the relationship between domain scores and functional outcomes remains unclear, leading to potential confusion about expectations after treatment. For instance, does a sexual function domain score of 80 mean that a patient can achieve erection sufficient for intercourse? Consequently we sought to determine the relationship between the domain score and the response to obtaining the best possible outcome for each question. MATERIALS AND

methodsUsing data from the CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation) study, a multicenter, prospective study of men diagnosed with localized prostate cancer, we analyzed 11,464 EPIC-26 questionnaires from a total of 2,563 men at baseline through 60 months of followup who were treated with robotic prostatectomy, radiotherapy or active surveillance. We dichotomized every item into its best possible outcome and assessed the percent of men at each domain score who achieved the best result.

resultsFor every EPIC-26 item the frequency of the best possible outcome was reported by domain score category. For example, a score of 80 to 100 on sexual function corresponded to 97% of men reporting erections sufficient for intercourse while at a score of 40 to 60 only 28% reported adequate erections. Also, at a score of 80 to 100 on the urinary incontinence domain 93% of men reported rarely or never leaking vs 6% at a score of 61 to 80.

conclusionsOur findings indicate a novel way to interpret EPIC-26 domain scores, demonstrating large variations in the percent of respondents reporting the best possible outcomes over narrow domain score differences. This information may be valuable when counseling men on treatment options.

Indexed as

Patient Reported Outcome MeasuresQuality of LifeRecovery of FunctionAdultAgedAged, 80 and overHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesProstatectomyProstatic NeoplasmsRadiotherapyRisk Factorspatient reported outcome measurespenile erectionprostatic neoplasmsquality of lifeurinary incontinence

Identifiers

PMID31216252
PMCPMC8627681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.